Clindamycin phosphate and Septic shock - a phase IV clinical study of FDA data

Summary:

Septic shock is reported as a side effect among people who take Clindamycin phosphate (clindamycin phosphate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ceftazidime, and have Staphylococcal infection.

The phase IV clinical study analyzes which people have Septic shock when taking Clindamycin phosphate. It is created by eHealthMe based on reports of 3,863 people who have side effects when taking Clindamycin phosphate from the FDA, and is updated regularly.

What is Clindamycin phosphate?

Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 4,216 Clindamycin phosphate users. Check the latest studies of Clindamycin phosphate.

What is Septic shock?

Septic shock (shock due to blood infection) is found to be associated with 1,727 drugs and 3,401 conditions by eHealthMe. Check the latest studies of Septic shock.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

3,863 people reported to have side effects when taking Clindamycin phosphate.
Among them, 29 people (0.75%) have Septic shock.

Could Clindamycin phosphate cause Septic shock?

Among these 29 people:

How long have people been on Clindamycin phosphate when they have Septic shock? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Septic shock when taking Clindamycin phosphate? *

  • female: 51.85 %
  • male: 48.15 %

What is the age of people who have Septic shock when taking Clindamycin phosphate? *

  • 0-1: 8.7 %
  • 2-9: 0.0 %
  • 10-19: 4.35 %
  • 20-29: 0.0 %
  • 30-39: 8.7 %
  • 40-49: 8.7 %
  • 50-59: 26.09 %
  • 60+: 43.48 %

What are other drugs people take besides Clindamycin phosphate? *

  1. Ceftazidime: 5 people, 17.24%
  2. Vancomycin Hcl: 4 people, 13.79%
  3. Famotidine: 4 people, 13.79%
  4. Metronidazole: 3 people, 10.34%
  5. Ambien: 3 people, 10.34%
  6. Vancomycin: 3 people, 10.34%
  7. Magnesium Sulfate: 3 people, 10.34%
  8. Meropenem: 3 people, 10.34%
  9. Flagyl: 3 people, 10.34%
  10. Carvedilol: 3 people, 10.34%

What are other side effects people have besides Septic shock? *

  1. Drug Ineffective: 6 people, 20.69%
  2. Pneumonia: 6 people, 20.69%
  3. Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 5 people, 17.24%
  4. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 17.24%
  5. Endocarditis (inflammation in heart muscle): 4 people, 13.79%
  6. Renal Impairment (severely reduced kidney function): 4 people, 13.79%
  7. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 13.79%
  8. Necrotising Fasciitis (an uncommon life-threatening soft-tissue infection): 3 people, 10.34%
  9. Catheter Related Infection: 3 people, 10.34%
  10. Interstitial Nephritis (inflammation of the kidney): 3 people, 10.34%

What are the existing conditions these people have? *

  1. Staphylococcal Infection (an infection with staphylococcus bacteria): 6 people, 20.69%
  2. Fever: 2 people, 6.90%
  3. Abdominal Pain: 2 people, 6.90%
  4. Aplastic Anemia: 2 people, 6.90%
  5. Aspergillosis (an infection caused by a fungus called aspergillus): 2 people, 6.90%
  6. Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 2 people, 6.90%
  7. Diarrhea: 2 people, 6.90%
  8. Necrotising Fasciitis (an uncommon life-threatening soft-tissue infection): 2 people, 6.90%
  9. Ill-Defined Disorder: 2 people, 6.90%
  10. Escherichia Bacteraemia (presence of bacteria escherichia coli in the blood): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Clindamycin phosphate and have Septic shock?

- Check whether Septic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clindamycin phosphate:

Septic shock treatments and more:

How severe was Septic shock and when was it recovered:

Expand to all the drugs that have ingredients of clindamycin phosphate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clindamycin phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Septic shock:

Browse all the conditions that are associated with Septic shock:


How the study uses the data?

The study uses data from the FDA. It is based on clindamycin phosphate (the active ingredients of Clindamycin phosphate) and Clindamycin phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: